Bioton S.A. (BIO) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.004x

Based on the latest financial reports, Bioton S.A. (BIO) has a cash flow conversion efficiency ratio of 0.004x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (zł2.49 Million ≈ $685.01K USD) by net assets (zł593.97 Million ≈ $163.47 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See BIO defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

Bioton S.A. - Cash Flow Conversion Efficiency Trend (2005–2025)

This chart illustrates how Bioton S.A.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.

Bioton S.A. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Bioton S.A. ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
LUDWIG BECK am Rathauseck - Textilhaus Feldmeier AG XETRA:ECK	-0.052x
Infant Bacterial Therapeutics AB (publ) ST:IBT-B	-0.420x
Delta Lithium Ltd AU:DLI	-0.007x
Smiths Group PLC LSE:SMIN	0.073x
Koryo Credit Information Co. Ltd KQ:049720	0.133x
MCOT Public Company Limited F:OLU1	0.043x
Sage Group PLC LSE:SGE	0.393x
Nonthavej Hospital Public Company Limited BK:NTV	0.041x

Annual Cash Flow Conversion Efficiency for Bioton S.A. (2005–2025)

The table below shows the annual cash flow conversion efficiency of Bioton S.A. from 2005 to 2025. For the full company profile with market capitalisation and key ratios, see Bioton S.A. market cap and net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	zł593.97 Million ≈ $163.47 Million	zł22.62 Million ≈ $6.23 Million	0.038x	-38.10%
2024-12-31	zł590.55 Million ≈ $162.53 Million	zł36.33 Million ≈ $10.00 Million	0.062x	-5.86%
2023-12-31	zł606.36 Million ≈ $166.88 Million	zł39.62 Million ≈ $10.91 Million	0.065x	-29.38%
2022-12-31	zł606.06 Million ≈ $166.80 Million	zł56.08 Million ≈ $15.43 Million	0.093x	+943.56%
2021-12-31	zł622.74 Million ≈ $171.39 Million	zł5.52 Million ≈ $1.52 Million	0.009x	-86.90%
2020-12-31	zł619.64 Million ≈ $170.54 Million	zł41.95 Million ≈ $11.54 Million	0.068x	-15.64%
2019-12-31	zł582.00 Million ≈ $160.17 Million	zł46.71 Million ≈ $12.85 Million	0.080x	+105.18%
2018-12-31	zł712.79 Million ≈ $196.17 Million	zł27.88 Million ≈ $7.67 Million	0.039x	+72.80%
2017-12-31	zł773.25 Million ≈ $212.81 Million	zł17.50 Million ≈ $4.82 Million	0.023x	-20.41%
2016-12-31	zł813.83 Million ≈ $223.98 Million	zł23.15 Million ≈ $6.37 Million	0.028x	-4.50%
2015-12-31	zł806.64 Million ≈ $222.00 Million	zł24.02 Million ≈ $6.61 Million	0.030x	+2.81%
2014-12-31	zł1.45 Billion ≈ $397.84 Million	zł41.87 Million ≈ $11.52 Million	0.029x	-49.82%
2013-12-31	zł1.39 Billion ≈ $381.20 Million	zł79.96 Million ≈ $22.01 Million	0.058x	-46.71%
2012-12-31	zł1.34 Billion ≈ $367.86 Million	zł144.80 Million ≈ $39.85 Million	0.108x	+775.77%
2011-12-31	zł1.38 Billion ≈ $381.14 Million	zł-22.20 Million ≈ $-6.11 Million	-0.016x	-169.02%
2010-12-31	zł1.17 Billion ≈ $321.97 Million	zł27.17 Million ≈ $7.48 Million	0.023x	+131.27%
2009-12-31	zł1.08 Billion ≈ $297.22 Million	zł-80.22 Million ≈ $-22.08 Million	-0.074x	-343.58%
2008-12-31	zł1.24 Billion ≈ $340.63 Million	zł37.74 Million ≈ $10.39 Million	0.030x	+5202.64%
2007-12-31	zł886.79 Million ≈ $244.06 Million	zł-530.00K ≈ $-145.86K	-0.001x	+95.51%
2006-12-31	zł808.11 Million ≈ $222.40 Million	zł-10.76 Million ≈ $-2.96 Million	-0.013x	-147.73%
2005-12-31	zł255.42 Million ≈ $70.29 Million	zł7.13 Million ≈ $1.96 Million	0.028x	--

About Bioton S.A.

WAR:BIO Poland Biotechnology

Market Cap

$93.82 Million

zł340.88 Million PLN

Market Cap Rank

#19514 Global

#153 in Poland

Share Price

zł3.97

Change (1 day)

-0.25%

52-Week Range

zł3.74 - zł4.65

All Time High

zł15.39